YOLFTbeta
Guangxi Wuzhou Zhongheng Group Co Ltd

Guangxi Wuzhou Zhongheng Group Co Ltd

600252 · SHG · Healthcare / Drug Manufacturers - Specialty & Generic

2.15CNY-0.07 (-3.15%)

Price History

Full chart

Market Stats

Previous Close2.22
Open2.22
Day Range2.13 – 2.24
52-Week Range1.71 – 3.10
Volume72.08M
Market Cap7.01B
P/E (TTM)0.00
Forward P/E12.99
EPS-0.14
Dividend Yield0.00%
Beta0.08
50-Day Avg2.24
200-Day Avg2.38

About

Guangxi Wuzhou Zhongheng Group Co., Ltd, together with its subsidiaries, researches, develops, manufactures, and sells pharmaceuticals in China. The company offers traditional Chinese medicine, including Xueshuantong injection, Zhonghua Dieda Wan for traumatic injuries, Fuyanjing capsules, JieShiTong tablets, snake gall and fritillaria liquid, Kunyuean granules, and compound clam oral liquid for cardiovascular and cerebrovascular, neurology, endocrinology, orthopedics, ophthalmology, gynecology, pediatrics, respiratory, urinary system, and other healthcare applications. It also provides clindamycin hydrochloride injection, esomeprazole sodium injection, esomeprazole magnesium enteric-coated capsules, cefoperazone dry suspension, naloxone hydrochloride injection, and fludarabine phosphate injection. Further, the company is involved in production of oral care, clothing care, and home care products, including toothpaste; health food business; pharmaceutical distribution; project investment and management; real estate development and operation; and cosmetic products businesses. Guangxi Wuzhou Zhongheng Group Co., Ltd was founded in 1993 and is based in Wuzhou, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Hui Ge
  • Employees2.84K
  • HeadquartersNo. 1 Industrial Avenue, Wuzhou, China, 543000, China
  • Websitehttps://www.wz-zhongheng.com

Leadership

  • Mr. Hui GeFinancial Officer · b. 1979
  • Mr. Ming ChenDeputy GM & Chief Technology Officer · b. 1967
  • Mr. Hai Run WangDeputy GM, General Counsel, Secretary, Chief Compliance Officer & Director · b. 1988
  • Mr. Weimin PengDeputy General Manager & Chief Quality Officer · b. 1968
  • Mr. Xiangyong WangDeputy General Manager · b. 1970
  • Mr. Tian Jiao WangDeputy General Manager · b. 1989
  • Peng LiAccounting Supervisor
  • Ms. Meifang JiangDeputy General Manager · b. 1989

Financials

Income Statement

Currency: CNY1997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue133.42M137.29M138.33M153.93M189.87M284.87M338.81M475.74M324.02M325.01M285.78M628.17M712.40M1.40B1.15B1.95B4.00B3.21B1.34B1.67B2.05B3.30B3.81B3.68B3.16B2.71B3.10B2.27B1.75B
Growth (%)-+2.90%+0.76%+11.27%+23.35%+50.03%+18.93%+40.41%-31.89%+0.31%-12.07%+119.81%+13.41%+96.18%-17.68%+69.11%+105.41%-19.57%-58.22%+24.35%+22.61%+61.10%+15.62%-3.61%-14.00%-14.17%+14.10%-26.67%-23.00%
Cost of Revenue89.51M91.17M98.14M101.71M132.61M183.92M221.61M300.25M179.65M160.55M119.79M399.85M355.02M553.65M360.55M541.32M772.63M716.35M369.33M458.64M385.89M347.57M624.33M824.55M839.51M1.10B1.23B1.33B977.54M
Gross Profit43.91M46.11M40.19M52.22M57.26M100.95M117.20M175.49M144.37M160.62M166.00M228.31M357.38M843.93M790.00M1.40B3.22B2.50B973.76M1.21B1.66B2.95B3.19B2.85B2.32B1.61B1.87B936.07M771.05M
Gross Margin32.91%33.59%29.05%33.92%30.16%35.44%34.59%36.89%44.56%49.42%58.08%36.35%50.17%60.39%68.66%72.18%80.67%77.71%72.50%72.54%81.16%89.46%83.63%77.57%73.45%59.35%60.42%41.22%44.10%
Operating Expense17.06M16.03M8.07M23.97M26.23M49.80M81.33M100.39M215.11M136.12M114.52M159.08M197.98M322.39M369.73M830.95M2.43B638.04M349.47M593.67M888.08M2.24B2.28B2.51B2.14B1.57B1.74B1.45B948.71M
Operating Income26.85M30.09M32.12M28.25M31.03M51.14M35.87M75.10M-70.74M24.50M51.48M69.23M159.40M521.54M420.28M573.45M796.40M1.86B624.28M617.75M773.75M707.40M907.34M346.68M177.93M43.40M132.69M-517.08M-177.66M
Operating Margin20.12%21.91%23.22%18.35%16.34%17.95%10.59%15.79%-21.83%7.54%18.01%11.02%22.38%37.32%36.53%29.47%19.93%57.86%46.48%36.99%37.79%21.44%23.79%9.43%5.63%1.60%4.28%-22.77%-10.16%
EBITDA30.76M29.79M30.18M45.83M43.84M63.58M57.62M86.15M-2.07M97.41M74.40M98.77M205.32M540.67M556.50M618.61M848.03M1.11B337.87M712.44M759.83M630.10M720.10M504.65M249.13M165.54M182.14M-33.37M-305.59M
EBITDA Margin23.05%21.70%21.81%29.77%23.09%22.32%17.01%18.11%-0.64%29.97%26.03%15.72%28.82%38.69%48.37%31.79%21.22%34.67%25.16%42.66%37.11%19.10%18.88%13.73%7.88%6.10%5.88%-1.47%-17.48%
Net Income22.22M25.32M31.01M26.18M29.07M27.17M26.73M2.09M-95.98M20.72M36.58M47.01M125.71M398.57M374.93M683.92M742.52M1.59B520.16M489.36M604.91M613.35M744.95M562.82M306.92M79.03M84.31M-376.98M-357.09M
Net Income Margin16.66%18.44%22.42%17.01%15.31%9.54%7.89%0.44%-29.62%6.37%12.80%7.48%17.65%28.52%32.59%35.15%18.58%49.61%38.73%29.30%29.54%18.59%19.53%15.31%9.71%2.91%2.72%-16.60%-20.42%
R&D--------------12.50M54.55M74.19M77.42M48.17M62.35M46.94M44.74M63.97M131.52M197.66M134.86M21.87M14.31M125.26M
R&D as % of Total Revenue--------------1.09%2.80%1.86%2.41%3.59%3.73%2.29%1.36%1.68%3.58%6.25%4.97%0.71%0.63%7.16%
Interest Expense4.67M4.66M-4.72M3.70M6.12M11.18M47.56M51.30M39.21M19.32M21.95M29.54M40.35M64.47M64.20M65.58M57.19M45.42M5.06M92.40K4.32K61.43K81.06M62.34M82.38M65.53M59.96M64.32M
Interest Expense % of Total Revenue3.50%3.39%-3.07%1.95%2.15%3.30%10.00%15.83%12.06%6.76%3.49%4.15%2.89%5.60%3.30%1.64%1.78%3.38%0.30%0.00%0.00%0.00%2.20%1.97%3.04%2.12%2.64%3.68%

Balance Sheet

Currency: CNY1997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets320.12M350.74M329.39M584.27M686.24M784.06M1.09B1.78B1.61B1.06B1.13B1.05B1.50B2.97B3.89B4.66B6.06B8.03B6.13B6.49B6.86B7.24B7.84B11.97B11.89B11.75B11.67B10.98B10.07B
Total Liabilities187.24M191.95M180.62M208.72M286.96M355.77M655.48M1.30B1.23B704.26M717.08M596.33M927.63M1.63B1.89B1.56B2.37B2.11B1.18B1.16B1.27B1.31B1.44B3.75B3.20B3.46B3.39B3.46B3.32B
Total Equity125.27M150.59M141.43M367.91M390.70M410.89M437.62M436.20M334.26M353.44M409.25M445.24M567.68M1.33B2.00B3.10B3.69B5.91B4.95B5.32B5.59B5.93B6.39B6.85B6.62B6.52B6.57B6.02B5.37B
Cash13.83M7.25M10.28M183.76M130.44M148.05M57.87M81.68M49.14M121.92M54.60M93.90M128.13M702.75M524.98M901.63M881.24M3.02B1.81B2.31B1.70B2.36B2.75B3.56B3.08B3.55B2.96B4.05B3.41B
Total Debt102.38M113.42M123.52M94.98M187.59M238.40M428.10M749.17M716.96M375.73M323.92M340.92M635.00M1.12B1.68B756.37M1.01B964.00M450.00M--6.77M111.00M1.76B1.56B1.96B1.58B1.78B-
Net Debt88.55M106.17M113.24M-88.78M57.16M90.35M370.23M667.49M667.82M253.81M269.32M247.02M506.87M417.25M1.15B-145.26M132.76M-2.06B-1.36B-2.31B-1.70B-2.35B-2.64B-1.81B-1.53B-1.59B-1.18B-2.28B-

Cash Flow

Currency: CNY1999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow52.29M-17.44M-11.74M-67.54M-122.95M144.06M56.14M199.41M40.75M59.47M-28.08M191.73M-375.93M906.43M945.10M569.95M291.53M1.50B893.21M853.40M654.31M656.62M-76.74M-170.09M484.10M477.43M-18.91M
Investing Cash Flow-12.73M-7.57M-106.88M52.40M-74.40M-64.74M-34.83M114.29M-11.74M-29.14M-195.94M-379.22M-229.17M466.90M-946.44M947.84M138.51M-548.37M-1.34B14.84M-17.12M-267.90M165.95M253.32M-812.05M949.45M-
Financing Cash Flow-36.54M198.49M65.29M30.93M107.16M-55.50M-53.85M-240.91M-76.34M-11.03M258.26M762.07M427.34M-996.69M-19.05M621.98M-1.74B-354.62M-156.74M-208.55M-247.92M134.64M-279.50M329.03M-290.82M-220.40M-
Capital Expenditure18.76M10.20M24.10M9.10M58.55M46.48M56.97M51.92M33.36M128.08M192.13M317.77M320.74M176.25M445.55M383.04M337.63M89.24M178.03M210.83M160.34M166.11M285.59M201.61M166.92M198.92M100.90M
Free Cash Flow33.53M-27.64M-35.84M-76.64M-181.50M97.58M-831.58K147.50M7.39M-68.61M-220.21M-126.04M-696.67M730.18M499.55M186.91M-46.11M1.41B715.18M642.57M493.97M490.51M-362.32M-371.70M236.10M278.50M-119.81M
Dividends Paid46.63M8.32M28.53M19.87M18.65M58.24M55.87M54.53M24.53M28.03M35.82M67.91M129.66M187.52M276.56M265.54M1.12B4.62M156.38M208.51M208.71M205.51M294.57M92.48M107.39M90.89M55.29M
FCF to OCF64.13%158.50%305.36%113.48%147.62%67.73%-1.48%73.96%18.14%-115.37%784.13%-65.74%185.32%80.56%52.86%32.79%-15.82%94.03%80.07%75.30%75.50%74.70%472.16%218.53%48.77%58.33%633.65%
Dividend Paid to FCF139.06%-30.11%-79.60%-25.93%-10.28%59.68%-6718.05%36.97%331.71%-40.85%-16.27%-53.88%-18.61%25.68%55.36%142.07%-2421.27%0.33%21.87%32.45%42.25%41.90%-81.30%-24.88%45.49%32.64%-46.15%

Earnings

Report DateMar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Dec 1, 2010Mar 2, 2011Apr 21, 2011Aug 31, 2011Oct 24, 2011Feb 29, 2012Apr 26, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Jul 24, 2014Oct 21, 2014Mar 19, 2015Apr 17, 2015Aug 13, 2015Oct 26, 2015Mar 28, 2016Apr 29, 2016Aug 23, 2016Oct 24, 2016Mar 30, 2017Apr 27, 2017Aug 23, 2017Oct 25, 2017Mar 29, 2018Apr 27, 2018Aug 24, 2018Oct 26, 2018Mar 28, 2019Apr 30, 2019Aug 23, 2019Oct 26, 2019Mar 26, 2020Apr 30, 2020Aug 29, 2020Oct 28, 2020Apr 30, 2021Aug 30, 2021Oct 29, 2021Apr 30, 2022Aug 27, 2022Oct 29, 2022Mar 29, 2023Apr 28, 2023
EPS Estimate--------0.07-0.04-0.02------------------------------------------
EPS Actual0.000.020.010.020.020.030.010.070.090.040.04-0.02-0.030.040.030.080.040.080.060.060.060.090.080.260.060.11-0.01-0.020.040.040.040.020.040.070.040.020.030.060.040.040.050.050.060.050.050.050.030.040.050.05-0.060.010.01-0.02-0.01
Surprise--------28.57%-0.00%--250.00%------------------------------------------
Timing--------Pre-market-After-hours-After-hours--------After-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-market--------------Pre-market----

Key Statistics & Ratios

Market Cap7.01B
Enterprise Value5.14B
Trailing P/E0.00
Forward P/E12.99
Price / Sales4.86
Price / Book1.32
EPS-0.14
Book Value1.64
Revenue (TTM)1.44B
Gross Profit (TTM)665.78M
EBITDA-113.52M
Profit Margin-29.94%
Operating Margin0.36%
Return on Equity-8.25%
Return on Assets-1.56%
Shares Outstanding3.18B
Shares Float2.21B
Beta0.08
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20241×
0.01Jun 24, 2024
20231×
0.01Jun 9, 2023
20221×
0.03Jun 10, 2022
20211×
0.09May 28, 2021
20201×
0.06Jun 5, 2020
20191×
0.06May 21, 2019
20181×
0.06May 29, 2018
20171×
0.04Jun 23, 2017
20152×
0.33Sep 16, 20150.20Jun 25, 2015
20141×
0.07Jul 4, 2014
20131×
0.07Jul 1, 2013
20121×
0.03Jun 25, 2012
20111×
0.01Jun 23, 2011
20101×
0.00Aug 30, 2010
20091×
0.00Jun 12, 2009
20061×
0.07Dec 19, 2006
20041×
0.00Oct 20, 2004
20031×
0.00Aug 21, 2003
20021×
0.00Jul 23, 2002
20011×
0.01Jun 21, 2001

Stock Splits

  • Sep 16, 201530:10
  • Jun 23, 201120:10
  • Jun 12, 200912:10
  • Dec 19, 200612.8:10
  • Oct 20, 200413:10
  • Aug 21, 200312:10
  • Jul 23, 200211:10